vs

Side-by-side financial comparison of 1stdibs.com, Inc. (DIBS) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is the larger business by last-quarter revenue ($44.6M vs $23.0M, roughly 1.9× 1stdibs.com, Inc.). 1stdibs.com, Inc. runs the higher net margin — -4.5% vs -90.4%, a 85.9% gap on every dollar of revenue. On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs 0.9%). 1stdibs.com, Inc. produced more free cash flow last quarter ($3.6M vs $-19.9M). Over the past eight quarters, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue compounded faster (7.3% CAGR vs 2.0%).

1stdibs.com, Inc. is an American e-commerce company. It has an online marketplace, which sells luxury items such as high-end furniture for interior design, fine art and jewelry. The company has been recognized for "pushing the antiques business into the 21st century." Originally, founded in Paris, it is headquartered in New York City.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

DIBS vs PACB — Head-to-Head

Bigger by revenue
PACB
PACB
1.9× larger
PACB
$44.6M
$23.0M
DIBS
Growing faster (revenue YoY)
PACB
PACB
+13.0% gap
PACB
13.8%
0.9%
DIBS
Higher net margin
DIBS
DIBS
85.9% more per $
DIBS
-4.5%
-90.4%
PACB
More free cash flow
DIBS
DIBS
$23.5M more FCF
DIBS
$3.6M
$-19.9M
PACB
Faster 2-yr revenue CAGR
PACB
PACB
Annualised
PACB
7.3%
2.0%
DIBS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DIBS
DIBS
PACB
PACB
Revenue
$23.0M
$44.6M
Net Profit
$-1.0M
$-40.4M
Gross Margin
73.5%
37.1%
Operating Margin
-10.1%
-92.3%
Net Margin
-4.5%
-90.4%
Revenue YoY
0.9%
13.8%
Net Profit YoY
80.0%
-1802.7%
EPS (diluted)
$-0.02
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DIBS
DIBS
PACB
PACB
Q4 25
$23.0M
$44.6M
Q3 25
$22.0M
$38.4M
Q2 25
$22.1M
$39.8M
Q1 25
$22.5M
$37.2M
Q4 24
$22.8M
$39.2M
Q3 24
$21.2M
$40.0M
Q2 24
$22.2M
$36.0M
Q1 24
$22.1M
$38.8M
Net Profit
DIBS
DIBS
PACB
PACB
Q4 25
$-1.0M
$-40.4M
Q3 25
$-3.5M
$-38.0M
Q2 25
$-4.3M
$-41.9M
Q1 25
$-4.8M
$-426.1M
Q4 24
$-5.2M
$2.4M
Q3 24
$-5.7M
$-60.7M
Q2 24
$-4.4M
$-173.3M
Q1 24
$-3.3M
$-78.2M
Gross Margin
DIBS
DIBS
PACB
PACB
Q4 25
73.5%
37.1%
Q3 25
74.3%
41.4%
Q2 25
71.8%
36.9%
Q1 25
72.4%
-3.7%
Q4 24
72.3%
25.6%
Q3 24
71.0%
25.0%
Q2 24
71.7%
16.5%
Q1 24
72.5%
29.1%
Operating Margin
DIBS
DIBS
PACB
PACB
Q4 25
-10.1%
-92.3%
Q3 25
-21.3%
-101.1%
Q2 25
-25.8%
-112.8%
Q1 25
-27.7%
-1154.5%
Q4 24
-30.6%
-390.1%
Q3 24
-34.9%
-160.3%
Q2 24
-29.2%
-488.3%
Q1 24
-24.3%
-209.6%
Net Margin
DIBS
DIBS
PACB
PACB
Q4 25
-4.5%
-90.4%
Q3 25
-16.0%
-98.9%
Q2 25
-19.5%
-105.4%
Q1 25
-21.3%
-1146.8%
Q4 24
-22.9%
6.0%
Q3 24
-26.8%
-151.9%
Q2 24
-20.0%
-481.3%
Q1 24
-15.0%
-201.4%
EPS (diluted)
DIBS
DIBS
PACB
PACB
Q4 25
$-0.02
$-0.11
Q3 25
$-0.10
$-0.13
Q2 25
$-0.12
$-0.14
Q1 25
$-0.14
$-1.44
Q4 24
$-0.14
$-0.44
Q3 24
$-0.15
$-0.22
Q2 24
$-0.12
$-0.64
Q1 24
$-0.08
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DIBS
DIBS
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$22.9M
$279.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$93.6M
$5.3M
Total Assets
$132.1M
$784.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DIBS
DIBS
PACB
PACB
Q4 25
$22.9M
$279.5M
Q3 25
$19.9M
$298.7M
Q2 25
$22.4M
$314.7M
Q1 25
$20.3M
$343.1M
Q4 24
$26.0M
$389.9M
Q3 24
$22.0M
$471.1M
Q2 24
$23.8M
$509.8M
Q1 24
$33.7M
$561.9M
Stockholders' Equity
DIBS
DIBS
PACB
PACB
Q4 25
$93.6M
$5.3M
Q3 25
$94.0M
$36.1M
Q2 25
$94.9M
$61.5M
Q1 25
$96.2M
$91.6M
Q4 24
$99.3M
$506.6M
Q3 24
$107.2M
$453.1M
Q2 24
$110.4M
$492.7M
Q1 24
$131.0M
$649.0M
Total Assets
DIBS
DIBS
PACB
PACB
Q4 25
$132.1M
$784.1M
Q3 25
$135.2M
$803.2M
Q2 25
$138.6M
$825.5M
Q1 25
$142.5M
$860.8M
Q4 24
$145.8M
$1.3B
Q3 24
$154.4M
$1.5B
Q2 24
$157.6M
$1.5B
Q1 24
$179.5M
$1.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DIBS
DIBS
PACB
PACB
Operating Cash FlowLast quarter
$4.3M
$-19.1M
Free Cash FlowOCF − Capex
$3.6M
$-19.9M
FCF MarginFCF / Revenue
15.7%
-44.6%
Capex IntensityCapex / Revenue
2.9%
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-3.2M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DIBS
DIBS
PACB
PACB
Q4 25
$4.3M
$-19.1M
Q3 25
$-1.5M
$-18.7M
Q2 25
$-5.1M
$-29.4M
Q1 25
$-96.0K
$-44.1M
Q4 24
$2.8M
$-30.6M
Q3 24
$-3.0K
$-45.5M
Q2 24
$-2.6M
$-54.3M
Q1 24
$-3.1M
$-75.7M
Free Cash Flow
DIBS
DIBS
PACB
PACB
Q4 25
$3.6M
$-19.9M
Q3 25
$-1.5M
$-18.8M
Q2 25
$-5.2M
$-29.9M
Q1 25
$-143.0K
$-45.4M
Q4 24
$1.5M
$-32.3M
Q3 24
$-44.0K
$-46.3M
Q2 24
$-3.0M
$-55.7M
Q1 24
$-3.3M
$-79.6M
FCF Margin
DIBS
DIBS
PACB
PACB
Q4 25
15.7%
-44.6%
Q3 25
-6.8%
-48.9%
Q2 25
-23.4%
-75.3%
Q1 25
-0.6%
-122.3%
Q4 24
6.5%
-82.3%
Q3 24
-0.2%
-115.7%
Q2 24
-13.5%
-154.8%
Q1 24
-14.8%
-205.0%
Capex Intensity
DIBS
DIBS
PACB
PACB
Q4 25
2.9%
1.9%
Q3 25
0.1%
0.2%
Q2 25
0.2%
1.4%
Q1 25
0.2%
3.7%
Q4 24
5.8%
4.1%
Q3 24
0.2%
2.0%
Q2 24
1.6%
4.1%
Q1 24
0.9%
10.0%
Cash Conversion
DIBS
DIBS
PACB
PACB
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-12.93×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DIBS
DIBS

Segment breakdown not available.

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons